CytoSorbents Corporation logo

CytoSorbents Corporation (CTSO)

Market Closed
26 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM)
$
4. 29
-0.98
-18.5958%
After Hours
$
4. 75
+0.46 +10.7226%
12.95M Market Cap
- P/E Ratio
- Div Yield
42,517 Volume
- Eps
$ 5.27
Previous Close
Investors:
Add Transaction
Day Range
4.1 5.3
Year Range
2.84 17.2
Want to track CTSO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

CytoSorbents Corporation (CTSO) Statistics

Valuation metrics

Market Cap 12.95M
Enterprise value 38.53M
Trailing P/E (ttm) -0.92
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 0.45
Price/Book (mrq) -22.04
Enterprise Value/Revenue 1.04
Enterprise Value/EBITDA -2.76

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 148.62K
Average volume (90 days) 30.95K

Price summary

52-Week low 2.84
52-Week high 17.2
Beta -
50-Day moving average 4.87
200-Day moving average 6.57

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 8 Sep 2026

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -0.49%
Operating margin -0.33%

Operational effectiveness

Return on assets -0.48%
Return on equity -4.45%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 11.85
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -5.8
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 1.41
Total debt (mrq) -
Total Debt/Equity (mrq) -35.07
Current ratio (mrq) 0.66%
Book value per share (mrq) -0.24

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -